Artiva biotherapeutics to participate in the jefferies global healthcare conference

San diego, may 28, 2025 (globe newswire) -- artiva biotherapeutics, inc. (nasdaq: artv), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, announced today that management will participate in a fireside chat at the jefferies global healthcare conference on wednesday, june 4, 2025, at 9:20 a.m. edt.
ARTV Ratings Summary
ARTV Quant Ranking